ReviewMedComm2026

Advancing In Vivo Chimeric Antigen Receptor T-Cell Engineering to Accelerate Clinical Translation.

Zhenxin Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.